KLS cells were collected from Cre (+) or Cre (–) mice and were transplanted as described above. PMF presence was determined +14 days after transplant. Mice with WBCs of > 8 × 103/ml and >25% donor-derived cells (CD45.2) were included. In preliminary experiments, 95% of mice meeting these criteria developed PMF (data not shown). Mice received tamoxifen 75 mg/kg or corn oil vehicle (MilliporeSigma) by intraperitoneal injection day +15–19 after transplant. Animals were monitored for survival and secondary endpoints. Only male mice were utilized to ensure no confounding hormonal or immune effects of tamoxifen in females (44–46).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.